Flatrock Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Buy
816
+76
+10% +$77.7K 0.38% 45
2026
Q1
$681K Sell
740
-4
-0.5% -$4.05K 0.31% 50
2025
Q4
$799K Buy
+744
New +$711K 0.38% 46

Other funds holding LLY

Flatrock Wealth Partners's LLY Position: Q2 2026 in Review

Flatrock Wealth Partners increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $77.7K and bringing the position to 816 shares worth $978K. The position accounts for 0.38% of the portfolio, ranked #45.

Flatrock Wealth Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,595 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Flatrock Wealth Partners held 816 shares of Eli Lilly worth $978K as of Q2 2026.
  • Flatrock Wealth Partners bought 76 Eli Lilly shares in Q2 2026, an estimated $77.7K.
  • Eli Lilly made up 0.38% of Flatrock Wealth Partners's portfolio in Q2 2026, its #45 holding.
  • Flatrock Wealth Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,595 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Flatrock Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.